Intrinsic Therapeutics named Wright Medical (NSQD:WMGI) veteran Cary Hagan as its new President & CEO. Greg Lambrect, founder of Intrinsic will stay on as executive director.

"Cary’s proven success in bringing new technologies to the global market makes him an ideal choice to lead Intrinsic’s next stage of growth as we expand our international clinical and commercial activity," said Lambrecht in prepared remarks.

The company won CE Mark approval in the European Union for its Barricaid annular prosthesis in April 2009. The device is a partial-disc prosthesis that enables surgeons to reconstruct the annulus (a fibrous ring around the edge of the intervertebral disc) during standard discectomies in patients with lumbar disc herniations and sciatica.

Sign up to get our free newsletters delivered right to your inbox.

"The Barricaid device has the potential to substantially reduce cases of recurrent herniation and back pain associated with failed discectomy — an outcome that could result in a multi-billion dollar economic benefit in the U.S. alone. I’m thrilled to join Intrinsic as we bring this revolutionary device into new global markets," Hagan added.

Hagan was let go from Wright Medical in May in wake of the company’s alleged kickbacks scheme.

Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.

• Brigagliano to leave SEC after 25 years
• Guggenhime and Monane join the CardioDx team

• Millipore’s Madaus takes the helm at VC-backed Quanterix
• Reimelt named vice president & CEO, GE Energy
• PPD appoints a new CEO
  
• Hanger Orthopedic puts a new man in charge of its prosthetic distribution unit
• AdvaMed names a new VP
  
• Malone resigns as Vicor’s director

• SANUWAVE appoints MedTech veteran Ron Sparks to board of directors
• President & CEO of Spectranetics elected as director of the board
• Milestone Scientific’s CFO, D’Agostino elected as COO
• InVivo Therapeutics gets a new VP of Operations
  
• Mahmoud Hafez joins ConforMIS scientific advisory board

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW